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Abstract
Herpes simplex virus type 1 (HSV-1) infection triggers a rapid induction of host innate immune responses. The type
I interferon (IFN) signal pathway is a central aspect of host defense which induces a wide range of antiviral proteins
to control infection of incoming pathogens. In some cases, viral invasion also induces DNA damage response,
autophagy, endoplasmic reticulum stress, cytoplasmic stress granules and other innate immune responses, which in
turn affect viral infection. However, HSV-1 has evolved multiple strategies to evade host innate responses and
facilitate its infection. In this review, we summarize the most recent findings on the molecular mechanisms utilized
by HSV-1 to counteract host antiviral innate immune responses with specific focus on the type I IFN signal pathway.
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Background
Herpes simplex virus type 1 (HSV-1) is a typical human-
restricted pathogen which is carried by 50–90 % of the
population worldwide, with the higher frequencies in
developing countries. HSV-1 is well known for its ability
to establish a lifelong latent infection in neurons and
trigger reactivation and lytic infection mainly in epithelial
or mucosal cells [1–3].
The type I interferon (IFN) signal pathway is the cru-
cial first line of defense and mediates a wide range of in-
nate immune responses toward viral infection. The type
I IFN signal pathway is activated upon recognition of
viral constituents by pattern-recognition receptors
(PRRs), then exerts its function through the expression
of multiple IFN-stimulated genes (ISGs) [4, 5]. Cytosolic
PRRs include several members of the Toll-like receptor
(TLRs) family and certain DNA and RNA sensors [6].
TLRs are the first to be discovered and identified PRRs
that detect pathogen-associated molecular patterns.
TLR3, TLR7, TLR8, and TLR9 locate on the endosomal
membrane and detect nucleic acids [7, 8]. RIG-I-like re-
ceptors (RLRs), including retinoic acid-inducible gene I
(RIG-I) and melanoma differentiation-associated gene 5
(MDA5) and other RNA receptors can detect distinct
RNA structures, while cytoplasmic DNA is detected by
recently discovered DNA sensors, including cyclic GMP-
AMP synthase (cGAS), IFN-γ-inducible protein 16 (IFI16),
DEAD box polypeptide 41 (DDX41), DNA-dependent acti-
vator of IRFs (DAI) and several proteins involved in the
DNA damage response [6, 9–11].
Apart from the type I IFN signal pathway, the host has
also evolved other host antiviral innate immune re-
sponses to counteract viral infection. Chromosomal
breaks at specific sites were induced upon HSV-1 infec-
tion, and viruses interact with cellular pathways respon-
sible for recognition and repair of DNA lesions also
known as the DNA damage response (DDR). Recent
studies show that certain aspects of DDR play a positive
role on antiviral defense [12, 13]. Autophagy, a con-
served cell-autonomous pathway, is involved in various
physiological processes, including antiviral responses
[14]. The canonical function of autophagy allows the
regular degradation and recycling of cellular components
through isolating targeted cytoplasmic constituents
within a double-membraned vesicle known as an autop-
hagosome and exerts several different antiviral roles.
Previous study indicates that HSV-1 infection leads to
endoplasmic reticulum (ER) stress, which could restrict
viral pathogenesis through modulating the immune re-
sponses or causing apoptosis [15]. Moreover, viral infection
also induces the formation of cytoplasmic granules known
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as stress granules (SGs). Evidence shows that there is a
strong correlation among SG formation, type I IFN
production and viral propagation, which suggests that
SGs could induce innate responses and restrain viral
infection [16].
However, to evade host innate responses, HSV-1 has
developed multiple mechanisms to attenuate host anti-
viral elements and facilitate its infection. In this review,
we will discuss the most recent findings on the molecu-
lar mechanisms utilized by HSV-1 to evade host antiviral
innate immune responses. Specific attention will be
given to type I IFN signal pathway, as it plays a central
role in the innate antiviral immunity.
HSV-1 infection dampens the type I interferon
production and its downstream signaling pathway
TLR signaling pathway
TLRs play a pivotal role in host defense against HSV-1
by detecting pathogen-associated molecular patterns and
subsequently recruiting downstream adaptor proteins
such as myeloid differentiation primary response protein
88 (MyD88), MyD88 adaptor-like protein (Mal), Toll/
interleukin 1 receptor domain-containing adaptor protein
(TIRAP), Toll/interleukin 1 receptor domain-containing
adaptor-inducing IFN-β (TRIF), and/or TRIF-related
adaptor molecule (TRAM). This leads to the formation of
distinct protein complexes, including TANK-binding
kinase 1 (TBK1) and inducible inhibitor of κB kinase
(IKK), which then activate transcription factors interferon
regulatory factor 3 (IRF3) and interferon regulatory factor
7 (IRF7) to further induce the expression of IFN-β. Until
now, TLR2, TLR3, TLR4 and TLR9 are reported to
recognize HSV-1 elements [8, 17, 18].
TLR3
TLR3 is well characterized for its ability to induce the
expression of type I IFNs and inflammatory cytokines
following detection of double-strand RNA, and is the
only TLR reported to play a non-redundant role in host
antiviral immunity. TLR3 deficient fibroblasts produced
much less IFN-I upon HSV-1 infection compared to
controls, and impaired TLR3 signaling also results in
high levels of viral replication [19–21]. Peri et al. reported
that HSV-1 tegument protein kinase US3 could reduce
the expression of TLR3 thus inhibiting TLR3-mediated re-
sponse, and depletion of US3 resulted in strong activation
of IRF3 and the type I IFN response [22].
MyD88
MyD88, composed of a Toll-interleukin-1 receptor do-
main and a death domain, is a crucial adapter molecule
in the TLR signal pathway [23]. Van Lint et al. reported
that expression of ICP0 alone was sufficient to reduce
the levels of MyD88 and Mal (TIRAP) through its E3
ligase function and cellular proteasomal activity, thus
reduced the TLR2-mediated inflammatory response
against HSV-1 infection [24].
TRAF6
TNF receptor associated factor 6 (TRAF6) is a member
of TRAF proteins, which play an important role as
adapter molecules to transmit intracellular signals [25].
TRAF6 interacts with TAK1 and the IKK complex, leading
to activation of the IKK complex, the latter then phos-
phorylates the inhibitor of κB, causing its ubiquitination
and degradation [26]. HSV-1 kinase US3 could also inhibit
TLR2 signaling by reducing TRAF6 polyubiquitination
which depends on its kinase activity [27].
RLR signaling pathway
RIG-I and MAD5
RLRs, best represented by RIG-I and MDA5, are proven
to play a crucial role during HSV-1 infection. RIG-I
mainly recognizes RNA bearing 5’-triphosphate group,
while MDA5 typically recognizes dsRNA that is over
2000 bps in length. Both RIG-I and MDA5 could transmit
signals to the downstream adaptor protein mitochondrial
antiviral-signaling protein (MAVS also known as IPS-1,
VISA, or CARDIF), which subsequently activates IRF3
and NF-κB and triggers the expression of type I IFNs and
inflammatory cytokines [28–30]. Previous studies in our
lab have demonstrated that several HSV-1 proteins could
down-regulate the RLR signaling pathway via targeting
multiple proteins involved in this pathway with distinct
mechanisms. US11, an RNA binding tegument protein of
HSV-1 [31], interacts with endogenous RIG-I and MDA5
via its carboxyl-terminal amino acids in an RNA inde-
pendent manner, and subsequently impedes the formation
of RIG-I/MAVS and MDA5/MAVS complexes, resulting
in reduced production of IFN-β [32].
TRAF3
TRAF3 is a crucial component of the RLR-mediated sig-
naling pathway and links upstream type I IFN signaling
responses of MAVS to TBK1 [33, 34]. K63-linked polyu-
biquitination of TRAF3 is indispensable for signaling by
MAVS and recruiting the kinases TBK1 and IκB kinase ε
(IKKε), leading to IRF3 phosphorylation and subsequent
type I IFN production. As the largest tegument protein
of HSV-1, UL36 is essential for HSV-1 replication and is
conserved across the herpesviridae family. UL36 contains
a deubiquitinase (DUB) motif within its N terminus also
known as UL36 ubiquitin-specific protease (UL36USP)
[35, 36]. The DUB activity of UL36USP is crucial to
block IFN-β production via deubiquitinating TRAF3
thus preventing the recruitment of the downstream
adaptor TBK1 [37].
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TBK1
TBK1 is an IκB Kinase-related kinase phosphorylating a
wide range of substrates involved in several cellular pro-
cesses. TBK1 is activated upon recognition of nucleic
acids by various DNA and RNA sensors, and triggers
phosphorylation of IRF3, activation of NF-κB and the
expression type I IFN. HSV-1 ICP34.5, a multifunctional
neurovirulence factor, contains 263 amino acids and is
essential in viral pathogenesis [38]. It has been shown
that HSV-1 ICP34.5 could inhibit IFN production by
binding and sequestering TBK1 [39, 40].
IRF3
IRF3 plays a crucial role in the innate immune responses
to viral infection, especially on activating the transcription
of type I IFN, and dimerization of IRF3 is a distinguishing
feature of early activation of the antiviral responses. HSV-
1 US3 is a serine/threonine protein kinase that is also con-
served across the herpesviridae family [41]. HSV-1 kinase
US3 could significantly down regulate the activation of
type I IFN and IFN-stimulated response element (ISRE)
depending on its protein kinase activity. Moreover, US3
hyperphosphorylates IRF3 to induce untypical phosphor-
ylation of IRF3 and inhibits its dimerization and nuclear
translocation. Infection of US3 KD mutant viruses,
K220M and D305A respectively, resulted in a much ro-
bust IFN-β production compared with wild-type virus
[42]. VP16 is an abundant 65-kDa virion phosphoprotein
that is delivered by the infecting virions and functions
during the earliest stages of infection to stimulate tran-
scription of the viral immediate-early genes, thereby facili-
tating the onset of the lytic program of viral gene
expression [43]. Our previous research revealed that VP16
could block the transactivation activity of IRF-3 through
interaction with IRF3 and interfering IRF-3 to recruit its
coactivator CBP [44]. ORF61 protein from varicella-zoster
virus is homologous to HSV-1 protein ICP0 [45]. Distinct
from that of ICP0, ORF61 inhibits IFN-β production
through degrading phosphorylated IRF3 via the ubiquitin-
proteasome pathway [46].
NF-κB
Activation of most PRRs, for example TLRs and RLRs,
leads to the induction of NF-κB signaling, which mediates
the expression of a large number of cytokines involved in
the innate immune responses, especially in the type I IFN
signal pathway [47, 48]. Recently, it is reported that NF-κB
also contributes to STING dependent, dsDNA-mediated
type I IFN production [49]. The p65/RelA subunit of NF-
κB is a crucial transcription factor in host innate immune
system. Many viruses, including RNA and DNA viruses,
antagonize the host inflammation responses at the p65/
RelA level. Conserved within alphaherpesvirus, US3
hyperphosphorylates p65 at serine 75 and abrogates its
nuclear translocation, resulting in inhibiting NF-κB activa-
tion and decreasing expression of many inflammatory
chemokine [50]. HSV-1 ICP0 is an immediate early and
multifunctional protein that plays a pivotal role during
both lytic and latent infections. ICP0 has an E3 ubiquitin
ligase activity that promotes degradation of certain host
proteins [51, 52]. Our previous study shows that ICP0 sig-
nificantly suppresses TNF-α-mediated NF-κB activation
through binding to the NF-κB subunits p65 and p50, and
ICP0 abolishes nuclear translocation of p65 and degrades
p50 through the ubiquitin-proteasome pathway depending
on its E3 ligase activity [53].
DNA sensors signaling pathway
Cytosolic DNA was known to induce immune responses
but the underlining mechanisms were not understood
until the recent discovery of multiple DNA sensors. Ishii
et al. found that double-strand B-form DNA could trigger
innate antiviral responses including production of type I
IFN and chemokines independent of TLRs or RIG-I [54].
During the past few years, great progress has been made in
discovering and characterizing several important cytosolic
DNA sensors which has greatly improved our understand-
ing of mechanisms of DNA sensor signaling pathway.
STING
Growing evidence shows that stimulator of interferon
genes (STING, also known as TMEM173, MITA, ERIS
and MPYS), expressed in T cells, DCs, macrophages,
endothelial cells, epithelial cells and fibroblasts, is an im-
portant adaptor for type I IFN induction by cytosolic
DNA and plays a critical role in innate immune signaling
[55–58]. STING is anchored in the endoplasmic reticulum
(ER) in unstimulated cells through four transmembrane
domains residing in its N-terminal region, while its C
terminus recruits TBK1 and IRF3, and facilitates the phos-
phorylation of IRF3 by TBK1. STING was recently identi-
fied as an ISG and ectopic expression of STING in
HEK293T cells could induce robust production of IFN-β
[59]. STING knockout mice were significantly more sus-
ceptible to HSV-1 compared with the wild-type siblings
[60], suggesting that STING might play an important role
in host restriction of HSV-1 infection. However, till now,
little is known about how HSV-1 evades STING mediated
immune responses. Kalamvoki et al. reported that HSV-1
infection affected the stability and function of STING in a
cell dependent manner, which depended on the functional
integrity of ICP0 and US3-PK [61].
cGAS
cGAS, also known as MB21D1 and C6orf150, belongs to
the nucleotidyltransferase family and shares highly related
structural and enzymatic features with the well-known
dsRNA-sensing 2 –5 -oligoadenylate synthase (OAS)
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proteins [62]. Using biochemical purification and quanti-
tative mass spectrometry, Sun et al. identified cGAS as a
novel and main sensor for cytosolic DNA [63, 64]. cGAS,
as well as STING, is an ISG, which undergoes a significant
conformational change after dsDNA binding and catalyzes
ATP and GTP to produce cyclic GMP-AMP (cGAMP), an
endogenous second messenger [63, 65, 66]. The latter
then binds to and induces dramatic conformational
change of STING, leading to its activation and subsequent
signal transduction. Depletion of cGAS using shRNA
abolished DNA induced activation of IRF3 and IFN-β pro-
duction. Similarly, cGAS knockout mice were significantly
more susceptible to HSV-1 infection compared with the
wild-type siblings, indicating that just as STING, cGAS
also played an important role in host defense against
HSV-1 infection [67]. Surprisingly, Orzalli et al. reported
that cGAS produced low amounts of cGAMP upon HSV-
1 infection whereas IFN-γ-inducible protein 16 (IFI16)
played a direct role in HSV DNA sensing [68]. Since
cGAS mediated signal transduction is completely
dependent on STING, viral proteins affecting STING or
its downstream molecules may directly affect the cGAS
pathway. Nonetheless, none of HSV-1 proteins has been
reported to specifically antagonize the cGAS/STING
mediated cytosolic DNA sensing signal pathway yet.
A high-throughput screen assay of all HSV-1 proteins
was performed in our lab to identify viral proteins involving
in immune evasion of the cGAS-STING signal pathway.
IFI16
IFI16 is a DNA binding protein and belongs to the
PYHIN family that contains an N-terminal pyrin domain
and two C-terminal HIN domains. Unlike other cellular
DNA sensors, IFI16 shuttles between the nucleus and
the cytoplasm, and is predominantly nuclear at resting
state [69–71]. Upon HSV-1 infection, IFI16 recognizes
and directly associates with viral genome in the nucleus,
then interacts with histone acetyltransferase p300.
Acetylation of IFI16 results in its cytoplasmic redistribu-
tion where it interacts with STING, and subsequently in-
duces IRF-3 phosphorylation as well as interferon-β
production to counteract viral replication [72]. One
study showed that IFI16 bound to HSV-1 promoters and
prevented association of transcriptional activators with
HSV-1 promoters, thus restricted HSV-1 replication
through modulating histone modifications [73]. Johnson
et al. and Orzalli et al. reported that HSV-1 specifically
targeted IFI16 for proteasomic degradation depending
on its E3 ubiquitin protein ligase ICP0 [74, 75], while
another report presented that expression of ICP0 alone
was not sufficient to degrade IFI16 and infection with
ICP0-null HSV-1 could also result in IFI16 degradation
[76], suggesting that other viral proteins may also be in-
volved in this process. HSV-1 infection could also induce
the activation of IFI16 leading to the formation of the
IFI16-ASC (apoptosis-associated speck-like protein con-
taining CARD)-procaspase-1 inflammasome complex
and maturation of IL-1β early during infection. ICP0
targeted IFI16 for degradation at later times to evade
the proinflammatory consequences [74]. Further studies
are necessary to fully understand dynamic interaction
between IFI16 and ICP0 and other viral proteins.
Other DNA sensors
Several proteins were identified as candidate cytosolic
DNA sensors before the discovery of cGAS, such as
DAI, DDX41, DNA-dependent protein kinase (DNA-PK)
et al. [6, 10]. Though these proteins were reported to
play a role on viral restriction, further studies showed
that they were dispensable for DNA-induced responses
in many human cells, suggesting that they might play a
redundant or cell-type specific role.
Interferon-stimulated genes
Type I IFNs trigger the induction of numerous ISGs,
including viperin, zinc finger antiviral protein (ZAP),
tetherin, double stranded RNA-dependent protein kinase
(PKR), 2’-5’ oligoadenylate synthetase (OAS), etc., and
distinct sets of ISGs cooperate to reinforce type I IFN
signaling and prime cells with enhanced antiviral activity
to inhibit viral replication. Here, we discuss how HSV-1
evades the antiviral activity of the aforementioned ISGs.
Viperin
Viperin (also known as RSAD2 or Cig5) is one of the
well-studied ISGs highly induced through both type I
IFN-dependent and type I IFN-independent pathways,
and restricts a broad range of viruses. HSV-1 UL41 was
an endoribonuclease with a substrate specificity similar
to that of RNase A [77]. Previous studies in our lab
showed that wild-type (WT) HSV-1 infection couldn’t
induce viperin production, and ectopically expression of
viperin inhibited the replication of UL41-null HSV-1 but
not WT viruses [78]. The underlying molecular mechan-
ism is that UL41 counteracts viperin’s antiviral activity
by reducing its mRNA accumulation [78].
ZAP
ZAP is a host restriction factor that prevents the ac-
cumulation of viral mRNA in the cytoplasm through
interacting with the ZAP-responsive elements in the
viral RNA [79]. HSV-1 UL41 protein abrogates the
antiviral activity of human ZAP by targeting its mRNA for
degradation, and consequently inhibiting the expression of
hZAP [80].
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Tetherin
Tetherin (also known as BST2 and CD317) is an ISG
which was initially identified as an antiviral effector by
inhibiting enveloped virus release without interaction
with viral proteins [81]. Tetherin was recently demon-
strated to restrict HSV-1 replication by suppressing virus
release, and HSV-1 envelope gM was identified as an an-
tagonist to tetherin restriction [82]. Further investigation
showed that HSV-1 efficiently depleted tetherin from
infected cells by reducing its mRNA via UL41, and that
depletion of tetherin could compensate for defects in
replication and release of UL41-null HSV-1 [83].
PKR
PKR is activated by dsRNA introduced to cells by many
viruses since dsRNA is a frequent by-product of viral
replication. Upon activation, PKR subsequently phos-
phorylates the eukaryotic translation initiation factor
EIF2A, which leads to the inhibition of cellular mRNA
translation, thereby preventing viral protein synthesis
and blocking viral production [84]. A recent report by
Low-Calle et al. showed that HSV-1 infection decreased
PKR constitutive expression [85].
OAS
Similar to PKR, OAS is also a key dsRNA-responsive ef-
fector. There are three major forms of OAS, all of which
recognize dsRNA through a positively charged groove in
the molecule. OAS undergoes a conformational change
after binding dsRNA and results in the synthesis of 2’,5’-
oligoadenylates (2-5As) [86]. These 2-5As products sub-
sequently activate latent RNase L, resulting in both viral
and endogenous RNA degradation and the inhibition of
viral replication [87]. Sànchez et al. reported that HSV-1
US11 protein was sufficient to block OAS activation
depending on its dsRNA-binding domain, and the
underlining mechanism could be that US11 sequestered
available dsRNA produced during infection [88].
Other host antiviral innate immune responses
DDR
DDR is an evolutionarily conserved response to detect
DNA damage and initiate cell-cycle arrest to repair the
damage. DDR pathways are mainly controlled by ataxia
telangiectasia mutated (ATM), ataxia telangiectasia and
Rad3 related (ATR) and DNA-PK. Viral DNA genome
can be sensed by DDR components which lead to the
inhibition of viral replication [12, 13, 89]. Recent re-
searches showed that several DDR sensors, such as
DNA-PK and MRE11, were also involved in cytosolic
DNA sensing and subsequently type I IFN production
[90, 91]. HSV-1 IE gene product ICP0 was reported to
prevent full activation of ATM response by promoting
the proteasome mediated degradation of DNA-PK,
RNF8 and RNF168 [92, 93]. Parkinson et al. found that
ICP0 alone was sufficient to degrade DNA-PKcs, the
catalytic subunit of DNA-PK, and virus yield was en-
hanced following infection of DNA-PK negative cells.
Chaurushiya et al. reported a novel mechanism utilized
by ICP0 to degrade RNF8 [94]. During HSV-1 infection,
ICP0 is phosphorylated by cellular CK1 kinase specifically
on T67, which facilitates its interaction with RNF8 via the
fork-head associated (FHA) domain and promotes RNF8
degradation [94].
Autophagy
Autophagy is an ancient cell-autonomous defense mech-
anism and plays a crucial antiviral role in restricting viral
invasion [14]. Most recently, Liang et al. found that the
autophagy protein Beclin1 directly interacted with
cytosolic DNA sensor cGAS, resulting in the inhibited
production of cGAMP by cGAS and enhanced
autophagy-mediated degradation of cytosolic DNAs
[95]. Surprisingly, autophagy deficiency does not sig-
nificantly increase the viral infectivity of HSV-1 [96],
which may due to potent strategies HSV-1 evolved to
antagonize autophagy. In fact, HSV-1 ICP34.5 was re-
ported to inhibit autophagy through a physical interaction
with Beclin 1 and control the formation of autophago-
somes in fibroblasts and neurons [97, 98].
ER stress
A variety of cellular stresses can severely perturb endo-
plasmic reticulum (ER) function, also known as “ER
stress”, triggering unfolded protein response (UPR) to
preserving ER homeostasis. There are currently three
UPR signaling pathways, distinguished by the action of
three ER-localized transmembrane proteins inositol-
requiring protein-1α (IRE1α), protein kinase RNA
(PKR)-like ER kinase (PERK), and activating transcrip-
tion factor 6 (ATF6) [15, 99]. HSV-1 glycoprotein gB
were reported to selectively inhibit PERK activation
[100]. Burnett et al. found that ICP0 promoter was re-
sponsive to ER stress which indicated that ICP0 might
act as a sensor of cellular ER stress response to effi-
ciently inhibit the UPR early in viral infection [101].
SGs
Cellular stresses as well as viral infection could induce
the formation of cytoplasmic proteins and RNA aggre-
gates also known as stress granules (SGs). Nucleoprotein
aggregates in SGs usually result in further storage, deg-
radation in another granular compartment, or restart of
translation upon recovery from stress. SGs are considered
to be antiviral as increasing evidence show that SG forma-
tion and viral propagation are negatively correlated in
multiple viral replication systems [102–104]. Finnen et al.
found that HSV-2 infection did not cause accumulation of
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SGs and identified HSV-2 vhs as a virion component
required for the disruption of SG formation [105]. In
addition, HSV-1 protein ICP8 was found to inhibit SG
formation by binding to G3BP [106], a crucial regulators
of the formation and stability of SGs.
Cell viability
Necrosis, a possible form of programmed cell death is a
crucial strategy to control viral replication and patho-
genesis [107, 108]. Treatment with tumor necrosis factor
(TNF)-α triggers necrosis and results in the interaction
between receptor-interacting kinase 1 (RIP1) and RIP3
through the RIP homotypic interaction motif (RHIM)
domains [109]. Recent investigations have shown that
HSV-1 R1 proteins ICP6 could prevent TNF-induced
necroptosis in human cells. ICP6 could form complexes
with both RIP1 and RIP3 via its RHIM domain hence abro-
gating the interaction between RIP1 and RIP3 [110, 111].
Conclusion
In summary, the interplay between HSV-1 and the host
antiviral innate immunity is very complicated, with viral
components interference at multiple steps of the host
antiviral defense signaling pathway (Fig. 1). Although the
host has evolved multiple mechanisms to detect and
trigger immediate antiviral responses, HSV-1 has also
evolved strategies to counteract the host antiviral im-
mune response. Notably, great progress has been made
in the past few years in identifying novel host antiviral
components, for example, the various cytosolic DNA
sensors, it also brings the challenge for us to unravel the
impact of these new elements on HSV-1 infection and
the strategy HSV-1 evolved to cope with these effectors.
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Fig. 1 HSV-1 mediated evasion of the type I IFN signal pathway. PRRs, such as TLRs, RLRs and cytosolic DNA sensors, could recognize pathogen-associated
molecular patterns. TLRs locate both at the plasma membrane and endosomes, and signal through TRIF and MyD88 to lead the activation of IRFs and
NF-κB. RIG-I and MDA5 detect distinct RNA structures and signal through the adaptor protein MAVS to trigger IRF3 and NF-κB activation. cGAS recognizes
dsDNA in the cytosol and subsequently catalyzes the production of cGAMP, a second messenger that activates the ER-localized adaptor protein STING.
STING recruits and activates TBK1, which then activates IRF3 to induce type I IFNs. Multiple steps in the type I IFN signal pathway can be hijacked by HSV-1
proteins. Green full lines indicate confirmed interactions between host molecules and HSV-1 proteins. Green dashed lines indicate uncertain interactions
that need to be further studied
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